| |
Left Ventricular Opacification: Rest and Stress Echo
Presentation 1: Salvaging the Difficult Echo: Quantitative and Qualitative LV Function
Presentation 2: Contrast Echo Stress Echo: Is it Worth the Effort?
| Release Date: May 9, 2008 |
|
Expiration Date: May 9, 2010 |
Technical Requirements
(will appear in new window)
Estimated Time of Completion |
30 minutes |
Description / Overview |
This activity was presented at the Cleveland Clinic 11th Diastology and New Echo Technologies featuring Contrast Echo Mini-Symposium. This on-demand webcast series focus on contrast echocardiography. |
Objectives |
At the conclusion of this activity, the participant will be able to:
- Evaluate the cardiac visualization results of intravenous contrast agents on harmonic imaging and fundamental imaging.
- Discuss the safety and efficacy data for use of contrast agents in stress echocardiography, both exercise and dobutamine induced.
- Assess a patient’s risk factors for potential serious adverse reactions to intravenous contrast agent administration.
|
Target Audience |
Cardiologists, sonographers, nurses and basic scientists, and other interested healthcare practitioners. |
Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2. |
Activity Director |
Allan L. Klein, MD
Director of Cardiovascular Imaging
Professor of Medicine
Department of Cardiology
Cleveland Clinic
Cleveland, Ohio |
Co-Activity Directors |
James D. Thomas, MD;
Craig R. Asher, MD;
Annitta J. Morehead, RDCS, FASE;
W. H. Wilson Tang, MD
|
Faculty |
Richard Grimm, DO, FACC |
Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Richard Grimm, DO, FACC |
|
| |
Teaching and Speaking |
Medtronic |
| |
Teaching and Speaking, Consulting |
St. Jude; General Electric |
| |
| W. H. Wilson Tang, MD |
|
| |
Consulting |
Medtronic |
| |
| James D. Thomas, MD |
|
| |
Consulting |
General Electric; Phillips; Siemens |
The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
Craig R. Asher, MD
Allan L. Klein, MD
Annitta J. Morehead, RDCS, FASE |
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Acusphere, Inc,
Bristol Myers Squibb
POINT Biomedical Corporation
This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
|